Streetbeat News

Earnings

ADMA

ADMA Biologics reported Q4 2023 earnings of $0.04 per share, surpassing the consensus estimate of $0.03. Sales reached $73.90M, exceeding the $72.15M estimate and marking a 47.86% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 9:28 pm

VYGR

Voyager Therapeutics (NASDAQ:VYGR) reported Q4 2023 earnings of $1.25 per share, surpassing the $(0.29) estimate, with sales of $90.06M also beating the $20.64M estimate. This represents a significant increase over the previous year's sales of $(1.55M).

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 9:27 pm

GOOG

GOOGL

RDDT

Reddit's IPO prospectus reveals a heavy reliance on advertising revenue, a significant partnership with Alphabet Inc. for data licensing, and challenges in turning a profit despite 19 years in operation. The company's valuation expectations above $5 billion raise questions given its current financials and strategy, including a directed share program aimed at creating demand among its user base.

Portfolio Pulse from Surbhi Jain

February 28, 2024 | 9:27 pm

SHLS

Shoals Technologies shares dropped following the announcement of disappointing Q4 financial results and lower than expected revenue guidance for Q1 and FY24.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 9:27 pm

CLMB

Climb Global Solutions (NASDAQ:CLMB) reported Q4 2023 earnings of $1.15 per share, surpassing the $0.68 estimate by 69.12%. Sales reached $106.78M, beating the $88.99M estimate by 19.99% and marking a 20.11% increase from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 9:27 pm

VCSA

Vacasa (NASDAQ:VCSA) reported Q4 2023 earnings with a GAAP EPS of $(3.48), surpassing the $(5.95) estimate. Sales reached $177.44M, exceeding the $173.86M forecast but marking an 18.66% decrease from the previous year.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 9:27 pm

AXP

American Express Company (NYSE:AXP) shares hit a record high of $219, marking a 55% increase in four months, the strongest since March 2021. Despite mixed recent news, optimistic 2024 guidance has fueled the rise. Insider sales and analyst ratings adjustments were noted, with a Hold rating from DBS Bank and a downgrade from Morgan Stanley but with an increased price target. Technical indicators suggest overbought conditions, but the stock is nearing a significant resistance line, indicating potential for further upward momentum.

Portfolio Pulse from Piero Cingari

February 28, 2024 | 9:27 pm

CWAN

Clearwater Analytics Holdings projects its FY24 revenue to be between $431M and $437M, which is below the estimated $440.143M.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 9:26 pm

AI

C3.ai, Inc. (NYSE:AI) reported Q3 financial results surpassing analyst expectations with a loss of 13 cents per share against an estimated loss of 28 cents, and sales of $78.4 million against an estimated $76.14 million. The company's year-over-year revenue grew by 18%, with significant growth in customer engagement and partner-supported bookings. C3.ai's stock soared by 15.80% after-hours to $34.33 following the announcement. The company forecasts Q4 revenue between $82 million to $86 million and anticipates a non-GAAP loss from operations for fiscal year 2024.

Portfolio Pulse from Erica Kollmann

February 28, 2024 | 9:26 pm

DUOL

Duolingo shares surged following the announcement of their Q4 financial results, which exceeded expectations. The company also provided optimistic future guidance.

Portfolio Pulse from Benzinga Newsdesk

February 28, 2024 | 9:26 pm